Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont/Evogene GM soybean deal

DuPont and Israeli plant genomics company Evogene (Rehovot) have entered into a multi-year collaboration to develop genetically modified disease-resistant soybeans. The companies will jointly develop a genomic database specifically tailored to soybean rust resistance. Evogene will use its “Athlete” computational genomic technology to identify novel genes and DuPont seed subsidiary Pioneer Hi-Bred International will evaluate the genes in GM soybean lines. Evogene will receive milestone payments and royalties on the sales of any resulting products.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG005462

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel